Front-office backlash: the EU gets tough on research unbundling

Three EU watchdogs – including CNMV and AFM – say front-office content can still be Mifid II research

Disclaimer: this is not a Risk.net article about research unbundling rules in the second Markets in Financial Instruments Directive; it is a sales tool. If you don’t believe us, you are in the same boat as European regulators.

A number of dealers had hoped to use similar disclaimers from the start of the Mifid II regime in January 2018, in a bid to safeguard front-office notes from the rules requiring fees for research to be separated from dealing commissions. The same rules also bar buy-side f

To continue reading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: